Previously, we isolated 2R,3S,15R-calofolic acids (CAs) from Calophyllum
scriblitifolium bark, which showed vasorelaxant activity
on phenylephrine (PE)-precontracted rat aortic rings. Although the
effect was suggested to be induced via an extracellular Ca2+-independent manner and mainly acts on vascular smooth muscle, the
exact mechanism of action of CAs remained unclear. Thus, this study
investigated the detailed mechanism of calofolic acid-A (CA-A) induced
vasorelaxation in an aortic ring specimen using rat vascular smooth
muscle cells (VSMCs). The levels of PE-induced phosphorylation on
MLC Ser19 decreased in VSMCs pretreated with CA-A. CA-A also decreased
the phosphorylation of MYPT1 Thr696 and MYPT1 Thr853. On the other
hand, CA-A increased the PE-induced phosphorylation of MYPT1 Ser695
and MYPT1 Ser668, which are reported to be phosphorylated by a cAMP-dependent
protein kinase (PKA). CA-A slightly increased PKA substrate phosphorylation
in a concentration-dependent manner. Furthermore, CA-A enhanced isoproterenol
(ISO)-induced cAMP accumulation and PKA substrate phosphorylation.
Treatment with PI-3 kinase (PI3K) inhibitor, LY294002, enhanced ISO-induced
cAMP accumulation and PKA substrate phosphorylation in the same manner
as CA-A treatment. Furthermore, CA-A was found to directly inhibit
PI3K enzyme activity in a dose-dependent manner. Taken together, the
present study indicated that CA-A induces vasorelaxation through an
indirectly activated PKA-MYPT1 pathway caused by inhibition of PI3K
activity.